Buyback18 May 2026, 06:01 pm
Windlas Biotech Completes Buyback, Extinguishes 4.7 Lakh Shares
AI Summary
Windlas Biotech Ltd. has completed the extinguishment of 4,70,000 fully paid-up equity shares with a face value of ₹5 each, pursuant to its buyback offer. The buyback process, initiated with a public announcement on April 18, 2026, concluded with the extinguishment confirmed by NSDL on May 18, 2026. Post-buyback, the paid-up equity share capital stands at 2,06,36,229 shares, amounting to ₹10,31,81,145.
Key Highlights
- Windlas Biotech extinguished 4,70,000 equity shares following its buyback offer.
- The extinguishment was confirmed by NSDL on May 18, 2026.
- Post-buyback, the company's paid-up equity share capital is ₹10,31,81,145.
- The buyback was conducted via tender offer at ₹1,000 per share.
- MUFG Intime India Private Limited acted as the Registrar to the Buyback.
Price Impact
More from WINDLAS*